Literature DB >> 25493018

Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis.

Hideaki Takahashi1, Ryuta Shigefuku1, Yoshihito Yoshida1, Hiroki Ikeda1, Kotaro Matsunaga1, Nobuyuki Matsumoto1, Chiaki Okuse1, Shigeru Sase1, Fumio Itoh1, Michihiro Suzuki1.   

Abstract

AIM: To elucidate the correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis (AL-LC).
METHODS: The subjects included 35 patients with AL-LC (34 men, 1 woman; mean age, 58.9 ± 10.7 years; median age, 61 years; range: 37-76 years). All patients were enrolled in this study after obtaining written informed consent. Liver function was measured with tests measuring albumin (Alb), prothrombin time (PT), brain natriuretic peptide (BNP), branched amino acid and tyrosine ratio (BTR), branched chain amino acid (BCAA), tyrosine, ammonia (NH3), cholinesterase (ChE), immunoreactive insulin (IRI), total bile acid (TBA), and the retention rate of indocyanine green 15 min after administration (ICG R15). Hepatic blood flow, hepatic arterial tissue blood flow (HATBF), portal venous tissue blood flow (PVTBF), and total hepatic tissue blood flow (THTBF) were simultaneously calculated using xenon computed tomography.
RESULTS: PVTBF, HATBF and THTBF were 30.2 ± 10.4, 20.0 ± 10.7, and 50.3 ± 14.9 mL/100 mL/min, respectively. Alb, PT, BNP, BTR, BCAA, tyrosine, NH3, ChE, IRI, TBA, and ICG R15 were 3.50 ± 0.50 g/dL, 72.0% ± 11.5%, 63.2 ± 56.7 pg/mL, 4.06 ± 1.24, 437.5 ± 89.4 μmol/L, 117.7 ± 32.8 μmol/L, 59.4 ± 22.7 μg/dL, 161.0 ± 70.8 IU/L, 12.8 ± 5.0 μg/dL, 68.0 ± 51.8 μmol/L, and 28.6% ± 13.5%, respectively. PVTBF showed a significant negative correlation with ICG R15 (r = -0.468, P <0.01). No significant correlation was seen between ICG 15R, HATBF and THTBF. There was a significant correlation between PVTBF and Alb (r = 0.2499, P < 0.05), and NH₃ tended to have an inverse correlation with PVTBF (r = -0.2428, P = 0.0894). There were also many significant correlations between ICG R15 and liver function parameters, including Alb, NH3, PT, BNP, TBA, BCAA, and tyrosine (r = -0.2156, P < 0.05; r = 0.4318, P < 0.01; r = 0.4140, P < 0.01; r = 0.3610, P < 0.05; r = 0.5085, P < 0.001; r = 0.4496, P < 0.01; and r = 0.4740, P < 0.05, respectively).
CONCLUSION: Our investigation showed that there is a close correlation between liver function and hepatic blood flow.

Entities:  

Keywords:  Alcoholic liver cirrhosis; Hepatic tissue blood flow; Indocyanine green; Liver function; Xenon computed tomography

Mesh:

Substances:

Year:  2014        PMID: 25493018      PMCID: PMC4258574          DOI: 10.3748/wjg.v20.i45.17065

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  The Fick principle: analysis of potential errors in its conventional application.

Authors:  M B VISSCHER; J A JOHNSON
Journal:  J Appl Physiol       Date:  1953-04       Impact factor: 3.531

2.  Hepatic hemodynamics and oxygen consumption in alcoholic fatty liver assessed by organ-reflectance spectrophotometry and the hydrogen clearance method.

Authors:  A Kasahara; N Hayashi; K Kurosawa; Y Sasaki; N Sato; T Kamada
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

3.  Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography.

Authors:  Shigeru Sase; Hideaki Takahashi; Ryuta Shigefuku; Hiroki Ikeda; Minoru Kobayashi; Nobuyuki Matsumoto; Michihiro Suzuki
Journal:  Med Phys       Date:  2012-12       Impact factor: 4.071

4.  Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response.

Authors:  S Richter; I Mücke; M D Menger; B Vollmar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-08       Impact factor: 4.052

5.  Hepatic arterial buffer response in patients with advanced cirrhosis.

Authors:  Veit Gülberg; Klaus Haag; Martin Rössle; Alexander L Gerbes
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

6.  Clinical characteristics of portal hemodynamics in alcoholic liver cirrhosis.

Authors:  Mami Hirata; Kiyotaka Kurose; Hisaka Minami; Teru Kumagi; S M Fazle Akbar; Koujirou Michitaka; Norio Horiike; Morikazu Onji
Journal:  Alcohol Clin Exp Res       Date:  2004-08       Impact factor: 3.455

7.  Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy.

Authors:  Hideaki Takahashi; Michihiro Suzuki; Ryuta Shigefuku; Miki Okano; Tetsuya Hiraishi; Rei Takagi; Yohei Noguchi; Nobuhiro Hattori; Moriaki Hatsugai; Kazunari Nakahara; Masaru Okamoto; Minoru Kobayashi; Hiroki Ikeda; Yasunobu Fukuda; Yoshihiko Nagase; Toshiya Ishii; Kotaro Matsunaga; Nobuyuki Matsumoto; Chiaki Okuse; Shigeru Sase; Fumio Itoh
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527

8.  Determination of time-course change rate for arterial xenon using the time course of tissue xenon concentration in xenon-enhanced computed tomography.

Authors:  Shigeru Sase; Hideaki Takahashi; Hiroki Ikeda; Minoru Kobayashi; Nobuyuki Matsumoto; Michihiro Suzuki
Journal:  Med Phys       Date:  2008-06       Impact factor: 4.071

9.  Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study.

Authors:  Lorette Noiret; Stephen Baigent; Rajiv Jalan
Journal:  Liver Int       Date:  2013-11-20       Impact factor: 5.828

10.  Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?

Authors:  Ryuta Shigefuku; Hideaki Takahashi; Minoru Kobayashi; Hiroki Ikeda; Kotaro Matsunaga; Chiaki Okuse; Nobuyuki Matsumoto; Shiro Maeyama; Shigeru Sase; Michihiro Suzuki; Fumio Itoh
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

View more
  8 in total

1.  Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt.

Authors:  Yasukazu Kako; Koichiro Yamakado; Wataru Jomoto; Toshiya Nasada; Koichiro Asada; Haruyuki Takaki; Kaoru Kobayashi; Takashi Daimon; Shozo Hirota
Journal:  Jpn J Radiol       Date:  2017-05-13       Impact factor: 2.374

2.  Insect tea extract attenuates CCl4-induced hepatic damage through its antioxidant capacities in ICR mice.

Authors:  Yuanjiang Liao; Xiaochuan Zou; Cun Wang; Xin Zhao
Journal:  Food Sci Biotechnol       Date:  2016-04-30       Impact factor: 2.391

3.  Influence of shunt occlusion on liver volume and functions in hyperammonemic cirrhosis patients having large porto-systemic shunts: a randomized control trial.

Authors:  Amar Mukund; Shakti Prasad Choudhury; Tara Prasad Tripathy; Venkatesh Hosur Ananthashayana; Rakesh Kumar Jagdish; Vinod Arora; Satender Pal Singh; Ajay Kumar Mishra; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2022-09-12       Impact factor: 9.029

4.  Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus.

Authors:  Ryuta Shigefuku; Hideaki Takahashi; Hiroyasu Nakano; Tsunamasa Watanabe; Kotaro Matsunaga; Nobuyuki Matsumoto; Masaki Kato; Ryo Morita; Yousuke Michikawa; Tomohiro Tamura; Tetsuya Hiraishi; Nobuhiro Hattori; Yohei Noguchi; Kazunari Nakahara; Hiroki Ikeda; Toshiya Ishii; Chiaki Okuse; Shigeru Sase; Fumio Itoh; Michihiro Suzuki
Journal:  Int J Mol Sci       Date:  2016-09-14       Impact factor: 5.923

5.  A Clinical-Radiomic Model for Predicting Indocyanine Green Retention Rate at 15 Min in Patients With Hepatocellular Carcinoma.

Authors:  Ji Wu; Feng Xie; Hao Ji; Yiyang Zhang; Yi Luo; Lei Xia; Tianfei Lu; Kang He; Meng Sha; Zhigang Zheng; Junekong Yong; Xinming Li; Di Zhao; Yuting Yang; Qiang Xia; Feng Xue
Journal:  Front Surg       Date:  2022-03-24

6.  Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function.

Authors:  Ryuta Shigefuku; Hideaki Takahashi; Tsunamasa Watanabe; Nobuhiro Hattori; Hiroki Ikeda; Kotaro Matsunaga; Takuya Ehira; Tatsuya Suzuki; Nobuyuki Matsumoto; Chiaki Okuse; Motoh Iwasa; Hayato Nakagawa; Fumio Itoh; Michihiro Suzuki
Journal:  BMC Gastroenterol       Date:  2022-07-21       Impact factor: 2.847

7.  Evaluation of liver function and electroacupuncture efficacy of animals with alcoholic liver injury by the novel imaging methods.

Authors:  Dong Zhang; Xiao-Jing Song; Shun-Yue Li; Shu-You Wang; Bing-Jun Chen; Xiao-Dong Bai; Li-Mei Tang
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

8.  Application of the optimized carbon monoxide rebreathing method for the measurement of total haemoglobin mass in chronic liver disease.

Authors:  James O M Plumb; James M Otto; Shriya B Kumar; Mark Wright; Walter Schmidt; Michael P W Grocott; Hugh E Montgomery
Journal:  Physiol Rep       Date:  2020-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.